BFBIO Stock Price and and Company Financials

BF Biosciences Limited

Price: Rs. 139.8 Rs. -1.20 (-0.86%)

Last updated: 2026-06-12
Share on Facebook

Annual Financials (Latest Year: 2025)

Sales
Rs. 5,837,466,000
Total revenue generated from core business operations during the year.
Profit After Tax
Rs. 447,147,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)
Rs. 5.52
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin
39.19%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin
7.66%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth
-9.36%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.
*Annual figures from latest financial statement
Open Close Low High Volume
141.00 139.80 138.11 142.05 210,323
From: To:

Top Stocks Players

Based on 2026-06-12 data
View all stocks players
Player Profit
image AJ
Lahore
+26.2%
image UDS idrees
RWP, Pakistan
+14.7%
image akhtar 2012
Karachi
+10.2%
image idrees barlas
Rawalpindi, Pakistan
+10.1%
image Muhammad ghazanfar
Sargodha, Pakistan
+9.1%
image kaly kachy wala
Gujranwala, Pakistan
+6.4%
image G1F22UBSAF009
Gujranwala, Pakistan
+5.6%
image Mukaram Bhatti
Gujranwala
+4.5%
image Muhammad “raza” Zaidi
Karachi, Pakistan
+4.3%
image G1F22UBSAF005
Gujranwala, Pakistan
+3.3%